An ultra-performance liquid chromatography-tandem mass spectrometry method to quantify vancomycin in human serum by minimizing the degradation product and matrix interference

Yaxin Fan, Xiaolin Peng, Jicheng Yu, Xiaoyu Liang, Yuancheng Chen, Xiaofen Liu, Beining Guo, Jing Zhang

Research output: Contribution to journalArticlepeer-review

Abstract

Aim: This study aimed to develop and validate a method for better therapeutic monitoring of vancomycin serum concentration.

Methods & results: An ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method was developed and validated to minimize the interference of crystalline degradation product and matrix. It was compared with chemiluminescence microparticle immunoassay (CMIA) and ultra-performance liquid chromatography with ultraviolet detection (UPLC-UV) in the performance of testing normal, on-dialysis and hemolytic serum samples. For on-dialysis samples, a moderate correlation (r = 0.534) was observed between UPLC-UV and UPLC-MS/MS. In testing hemolytic samples, ten (10/85, 11.8%) samples were overestimated by CMIA method.

Conclusion: Vancomycin concentration determined by CMIA, UPLC-UV was more affected by various panels of serum samples than UPLC-MS/MS assay, suggesting that UPLC-MS/MS is a more reliable and promising tool for clinical vancomycin therapeutic drug monitoring.
Original languageEnglish
Pages (from-to)941-955
Number of pages15
JournalBioanalysis
Volume11
Issue number10
Publication statusPublished - 20 Jun 2019

Keywords

  • therapeutic drug monitoring
  • ultra-performance liquid chromatography
  • tandem mass spectrometry
  • Vancomycin

Fingerprint

Dive into the research topics of 'An ultra-performance liquid chromatography-tandem mass spectrometry method to quantify vancomycin in human serum by minimizing the degradation product and matrix interference'. Together they form a unique fingerprint.

Cite this